---
title: 'Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13
  clinical studies using genotype imputation: a meta-analysis'
date: '2024-07-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39025838/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240719181339&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Cytochrome P450 enzymes including CYP2C19 and CYP2D6 are important for
  antidepressant metabolism and polymorphisms of these genes have been determined
  to predict metabolite levels. Nonetheless, more evidence is needed to understand
  the impact of genetic variations on antidepressant response. In this study, individual
  clinical and genetic data from 13 studies of European and East Asian ancestry populations
  were collected. The antidepressant response was clinically assessed as remission
  ...
disable_comments: true
---
Cytochrome P450 enzymes including CYP2C19 and CYP2D6 are important for antidepressant metabolism and polymorphisms of these genes have been determined to predict metabolite levels. Nonetheless, more evidence is needed to understand the impact of genetic variations on antidepressant response. In this study, individual clinical and genetic data from 13 studies of European and East Asian ancestry populations were collected. The antidepressant response was clinically assessed as remission ...